It's (arguably) not the market here that's the problem, but the patent. The patent means that generic manufacturers can't get in on the market and create a commodity out of it with a race to the bottom on price. The problem isn't the market, but the absolute lack of a market created by the exclusivity of a patent.
We need to find a way as a society that these companies can profit off the research and development of these drugs while still allowing generic manufacturers to do what they do best: create a real, competitive market to produce the drug in bulk.
Unfortunately I don't think there's any clear answers here.
Wasnt that how NASA was supposed to work ? Oh wait, we know how it went...
It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices.
Fixing patents, wouldn't necessarily fix this problem.
you don't raise prices on drugs that easily, Prices changes are heavily regulated as well.
It's far from being a market-forces driven market. Pharma pricing is a heavily regulated market involving parties which are not the end consumer (Pricing Authorities, FDA, Pharma Companies, Insurance Companies, and sometimes Patient Advocate Groups).
That has about NOTHING to do with Free Market ideals.
If pharmas set a certain pricing, the patients+insurers/Medicare feel the effect of that pricing, and respond accordingly. Patients have no choice but to take the price, and demand that insurers provide coverage for all cancer drugs. Insurers then spread the costs across their pool of insurees, resulting in skyrocketing premiums.
Did you know that Medicare isn't allowed to negotiate the prices of drugs, as part of regulatory concessions to pharma companies made in 2003?[1] What happens when Medicare (unlike other insurers) is forced to always pay what drug companies demand?
Further, in the case of Gleevec, the basic drug molecule was discovered by a university researcher, who went to Novartis to get it to invest in trials. So the costs aren't even fully borne by Novartis.
The system is broken and some possible solutions (proposed by researchers including those who discovered the drugs) should be evaluated. But strong lobbying from pharma is hard to get around.
[1] ...the 2003 Medicare Prescription Drug, Improvement, and Modernization Act contains legislation that forbids Medicare from negotiating drug prices. These policies have created an opportunity for drug companies, rendering them the sole decision makers on the price of cancer drugs. http://www.mayoclinicproceedings.org/article/S0025-6196%2815...
Make this a vote by the people instead of relying on your leaders to make such changes. Referendums can be used for important measures.
For Gleevec, almost surely yes. But what about other undiscovered drugs?
hello ? Prices are regulated by governments in most countries. You should start acting to make your government stop inflation on drug prices. Pharma companies can only abuse the system if you let them.
If the US system of insane drug prices leads to 10x the drugs of a system of capped drug prices, I could see an argument to be made that insane drug prices are saving lives.
US market because that's the largest pharma market in the world, and it's the most friendly to businesses as well (since you can do direct to consumer advertising for pharma drugs, which is forbidden is about every other country). It's kind of natural that this is the market with the most innovation, but also where prices go the craziest, because of the way the insurance system is structured,
https://www.change.org/p/secretary-of-health-and-human-servi...
Prices have increased more than tenfold between 2000 (average price $5,000-$10,000 per year) and today (average price of new cancer drugs exceeds $120,000 per year).
http://www.nytimes.com/2015/01/15/opinion/why-drugs-cost-so-...
Novartis, the company that makes the leukemia drug Gleevec, keeps raising the drug’s price, even though the drug has already delivered billions in profit to the company. In 2001 Novartis charged $4,540, in 2014 dollars, for a month of treatment; now it charges $8,488. In its pricing, Novartis is just keeping up with other companies as they charge more and more for their drugs. They know we can’t say no.
http://www.nbcnews.com/health/cancer/utterly-broken-drug-mar...
Lauren Baumann is one of the lucky ones. Though she has cancer, chronic myeloid leukemia, it is manageable, as long as she takes a daily pill called Gleevec. Gleevec is considered a wonder drug, turning Lauren's leukemia from a death sentence to a disease she and thousands of others can live with. The problem is, even with health insurance and a full-time job, Lauren can't afford the monthly co-pay for Gleevec. It can be as high as $2,000 a month — twice the average mortgage payment in the U.S.
"I feel like you get punished," says Baumann. "I didn't ask to get cancer; I didn't ask to get sick. I was 26 and I was perfectly healthy."
This is essentially extortion due to price inelasticity of demand. $9,000-$12,500/month to survive, for the rest of your natural life! Patients+insurers have to pay whatever price the companies ask. For something as crucial as a life-saving drug, maybe the prices shouldn't be set only by market forces? Maybe generics should be allowed for import after patents expire the first time around?
(There are analyses of drug discovery costs around, and even after all those costs and reliance on basic research funded by taxpayer money, pharma companies make a very healthy profit. Much of the money goes into marketing, which we wouldn't need so much of in a system similar to the NHS which approves drugs for dispensing countrywide.)
Please sign the above Change.org petition (first link) and spread it! I normally don't make appeals, but this is one truly egregious case of unethical profiting.
An international panel of 115 doctors co-authored a paper decrying these ridiculous prices and offering 7 solutions, including allowing Medicare to negotiate drug prices once again (which they now aren't allowed to!):
http://www.forbes.com/sites/matthewherper/2015/07/23/155-ang...